Machines are getting smarter every day, and companies across the world are discovering new ways in which they can use AI to significantly enhance engagement and customer experience. That is why decision-makers from pharmaceutical companies, hospitals and healthcare providers gather to network and discuss the latest innovations, as well as the potential for both AI and robotics, at Healthcare Automation and Digitalization Congress 2023 in Zurich, Switzerland, on September, 25-26.
Companies keep searching for new ways of unleashing the full potential of AI and robotics in the healthcare industry. This way, during the business program of AUTOMA+2023, the participants will discuss and share the insights on AI generative algorithms, value creation with AI, as well as smart use cases. Among the participants are the delegates from Spital Thurgau, Sana Kliniken AG, Oxford University Hospital, Humanitas Research Hospital, Mater Hospital, Kantonsspital Aarau AG, Odense University Hospital, Idorsia Pharmaceuticals Ltd, Pfizer, Merck, Takeda, GSK and many others.
From finding new links between genetic codes to making robotic-assisted surgery, AI simplifies the lives of patients, doctors, and hospital administrators. Artificial intelligence helps address many tasks, for example:
Some of the speakers of AUTOMA+ 2023 who are ready to present their thoughts on AI implementation in healthcare are:
Ronak Mathur, Automation Architect at Mater Hospital, who is going to talk about value creation with automation and AI in healthcare with the right framework.
Another speaker, Michelle Bridenbaker, Global Lead Medical Information and Communications at Idorsia Pharmaceuticals Ltd., is going to present the smart use cases for Artificial Intelligence in Medical Affairs.
To conclude, AI is getting increasingly advanced at doing what humans do, but more efficiently, more quickly and at a lower cost. The potential for both AI and robotics in healthcare is vast. During AUTOMA+ 2022, the delegates were asked about what innovations in digital health they consider as the most promising for the industry. Anna Erat, Medical Director at Hirslanden Klinik, emphasised: “I think it is AI. I don’t think you can ever substitute medical professionals, but complement them. So within the field of radiology and neurobiology cancer screening you can really implement various fascinating solutions like AI.”
Request the full business program for AUTOMA+ Health 2023: https://sh.bgs.group/vp
